The Complexity of Bariatric Patient’s Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass
Open Access
- 18 December 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (12) , 2795
Abstract
Postbariatric altered gastrointestinal (GI) anatomy/physiology may significantly harm oral drug absorption and overall bioavailability. In this work, sildenafil, the first phosphodiesterase-5 (PDE5) inhibitor, was investigated for impaired postbariatric solubility/dissolution and absorption; this research question is of particular relevance since erectile dysfunction (ED) is associated with higher body mass index (BMI). Sildenafil solubility was determined both in vitro and ex vivo, using pre- vs. postsurgery gastric contents aspirated from patients. Dissolution tests were done in conditions mimicking the stomach before surgery, after sleeve gastrectomy (post-SG, pH 5), and after one anastomosis gastric bypass (post-OAGB, pH 7). Finally, these data were included in physiologically based pharmacokinetic (PBPK) modelling (GastroPlus®) to simulate sildenafil PK before vs. after surgery. pH-dependent solubility was demonstrated with low solubility (0.3 mg/mL) at pH 7 vs. high solubility at pH 1–5, which was also confirmed ex vivo with much lower solubility values in postbariatric gastric samples. Hampered dissolution of all sildenafil doses was obtained under post-OAGB conditions compared with complete (100%) dissolution under both presurgery and post-SG conditions. PBPK simulations revealed delayed sildenafil absorption in postbariatric patients (increased tmax) and reduced Cmax, especially in post-OAGB patients, relative to a presurgery state. Hence, the effect of bariatric surgery on sildenafil PK is unpredictable and may depend on the specific bariatric procedure. This mechanistically based analysis suggests a potentially undesirable delayed onset of action of sildenafil following gastric bypass surgery.Keywords
This publication has 69 references indexed in Scilit:
- Evaluation of anIn SilicoPBPK Post‐Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and CyclosporineCPT: Pharmacometrics & Systems Pharmacology, 2013
- Weight loss is a major contributor to improved sexual function after bariatric surgerySurgical Endoscopy, 2013
- A Randomized, Open‐Label, 3‐Way Crossover Study to Demonstrate Bioequivalence of Sildenafil Powder for Oral Suspension With Tablets Used Commercially and in Clinical Studies for the Treatment of Pulmonary Arterial HypertensionClinical Pharmacology in Drug Development, 2012
- Diabetes, Obesity and Erectile Dysfunction: Field Overview and Research PrioritiesJournal of Urology, 2009
- Site of drug absorption after oral administration: Assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tractEuropean Journal of Pharmaceutical Sciences, 2006
- In Vitro Dissolution Studies of Sodium Diclofenac Granules Coated with Eudragit L-30D-55® by Fluidized-Bed SystemDrug Development and Industrial Pharmacy, 2006
- Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imagingAlimentary Pharmacology & Therapeutics, 2005
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBritish Journal of Clinical Pharmacology, 2002
- Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and manXenobiotica, 1999
- Dissolution of Theophylline from Film-coated Slow Release Mini-tablets in Various Dissolution MediaJournal of Pharmacy and Pharmacology, 1989